Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-05
1998-03-10
Trinh, Ba K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514460, 549280, 549282, A61K 31365, C07D31194, C07D49306
Patent
active
057262047
ABSTRACT:
The present invention is directed to compounds that are analogs of the natural product suksdorfin. Compounds of the present invention include those having Formula I: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are defined herein. The invention is also directed to methods of making these compounds, pharmaceutical compositions including these compounds and methods of using the compounds to inhibit retroviral infections in cells and tissues of animals. A method for stereoselectively preparing compounds within the scope of the invention by catalytic asymmetric dihydroxylation is also disclosed.
REFERENCES:
patent: 2980699 (1961-04-01), Smith et al.
patent: 5089634 (1992-02-01), Powers et al.
patent: 5177073 (1993-01-01), Gulliya et al.
patent: 5324648 (1994-06-01), Powers et al.
Taylor, et al.; "Kinetic and Mutational Analysis of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibition by Inophyllums, a Novel Class of Non-nucleoside Inhibitors"; Journal of Biological Chemistry; vol. 269, No. 9; 6325-6331; Mar. 4, 1994.
Lunney, et al.; "A Novel Nonpeptide HIV-1 Protease Inhibitor: Elucidation of the Binding Mode and Its Application in the Design of Related Analogs"; J. Med. Chem.; vol. 37, No. 17; 2664-2677; 1994.
Greenspan et al.; "Could Oxidative Stress Initiate Programmed Cell Death in HIV Infection? A Role for Plant Derived Metabolites Having Synergistic Antioxidant Activity"; Chemico-Biological Interactions; vol. 91; 187-197; 1994.
Patil, et al.; "The Inophyllums, Novel Inhibitors of HIV-1 Reverse Transcriptase isolated from the Malaysian Tree, Calophyllum Inophyllum Linn"; Journal of Medicinal Chemistry; vol. 36, No. 26; 4131-4138; Dec. 24, 1993.
Boyer, et al.; "Analysis of Nonnucleoside Drug-Resistant Variants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase"; Journal of Virology; vol. 67, No. 4; 2412-2420; Apr., 1993.
Zmudzka, et al.; "Activation of the Human Immunodeficiency Virus Promoter by UVA Radiation in Combination with Psoralens or Angelicins"; Photochemistry and Photobiology; vol. 58, No. 2; 226-232; 1993.
Hatano, et al.; "Phenolic Constituents of Licorice. II. Structures of Licopyranocoumarin, Licoarylcoumarin and Glisoflavone, and Inhibtory Effects of Licorice Phenolics on Xanthine Oxidase"; Chem. Pharm. Bull.; vol. 37, No. 11; 3005-3009; Nov., 1989.
Kashman, et al.; "The Calanolides, a Novel HIV-Inhibitory Class of Coumarin Derivatives from the Tropical Rainforest Tree, Calophyllum Lanigerum"; J. Med. Chem.; vol. 35, No. 15; 2735-2743; 1992.
Bourinbaiar, et al.; "Effect of the Oral Anticoagulant, Warfarin, on HIV-1 Replication and Spread"; AIDS; vol. 7, No. 1; 129-130; 1993.
Greenspan, et al.; "Oxidative Stress and Apoptosis in HIV Infection: a Role for Plant-Derived Metabolites with Synergistic Antioxidant Activity"; Immunology Today; vol. 15, No. 5; 209-213; 1994.
Bourinbaiar, et al.; "Inhibitory Effect of Coumarine on HIV-1 Replication and Cell-Mediated or Cell-Free Viral Transmision"; Acta Virol.; vol. 37; 241-250; 1993.
Kimura, et al.; "Effects of Active Compounds Isolated From Angelica Shikokiana on Lipid Metabolism in Fat Cells"; Journal of Ethnopharmacology; vol. 25; 269-280; 1989.
Nishino, et al,; "Studies on the Anti-Tumor-Promoting Activity of Naturally Saselin-Type Coumarin, Inhibits the Promotion of Skin Tumor Formation by Anthracene-Initiated Mice"; Carcinogenesis; vol. 11, No. 9; 1557-1561; 1990.
Meyer, et al.; "Plant Antitumor Agents, 21. Flavones, Coumarins, and an Alkaloid from Sargentia Greggli"; Journal of Natural Products; vol. 48, No. 6; 952-956; Nov.-Dec., 1985.
Thastrup, et al,; "Inhibition of Human Platelet Aggregation by Dihydropyrano- and Dihydrofuranocoumarins, a New Class of cAMP-Phosphodiesterase Inhibitors"; Biochemical Pharmacology; vol. 34, No. 12; 2137-2140; 1985.
Delgado, et al.; "Pyranocoumarins from Arracacia Nelsonii"; Biochemistry; vol. 26, No. 4; 1139-1141; 1987.
Baccichetti, et al.; "Photobiological Activity of Certain Pyranocoumarin Derivatives: Potential Agents for the Photochemotherapy of Psoriasis"; Photodermatology; vol. 3; 261-270; 1986.
Kashman, et al,; "Additions and Corrections"; J. Med. Chem.; vol. 35; 1110; 1992.
Huang et al, 3'4'-DI-O-(-)-Camphanoyl-(+)-CIS-Khellactone and Related Compounds: A New Class of Potent Anti-Hiv Agnets, Bioorganic and Medicinal Chemistry Letters, vol. 4, No. 4, pp. 593-598, Feb. 23, 1994.
Vichkonova et al, Antimicrobial and Antiviral Activity of Some natural Coumarins, Chemical Abstracts vol. 79, No. 19, p. 49, Abstract No. 111980v, Nov. 12, 1973.
Schroeder et al, Struktur der Visnagane; Synthese von (+-)-Trans-Samidin, Chemische Berichte, vol. 92, pp. 2338-2363, 1959.
Antonova, et al, Dihydrosamidin and Visnadin, Chemical Abstracts, vol. 96, No. 12, p. 407, Abstract No. 96:91638k, Mar. 22, 1982.
Bohlmann et al, Synthese von Racemischem Lomatin, Columbianetin, Angenomalin und Samidin, Chemische Berichte, vol. 104, pp. 3229-3233, 1971 .
Cosentino Mark
Huang Li
Kashiwada Yoshiki
Lee Kuo-Hsiung
Lee Thomas Tung-Ying
Biotech Research Laboratories
Trinh Ba K.
University of North Carolina at Chapel Hill
LandOfFree
Suksdorfin analogs, compositions thereof, and methods for making does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suksdorfin analogs, compositions thereof, and methods for making, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suksdorfin analogs, compositions thereof, and methods for making will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-140001